Cargando…
An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP)
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disorder involving production of autoantibodies against endogenous granulocyte–macrophage colony-stimulating factor (GM-CSF). This study aimed to identify biomarkers that could be used to monitor for aPAP, particularly in patients treat...
Autores principales: | Campo, Ilaria, Meloni, Federica, Gahlemann, Martina, Sauter, Wiebke, Ittrich, Carina, Schoelch, Corinna, Trapnell, Bruce C., Gupta, Abhya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130212/ https://www.ncbi.nlm.nih.gov/pubmed/35610268 http://dx.doi.org/10.1038/s41598-022-11446-8 |
Ejemplares similares
-
A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP)
por: Mariani, Francesca, et al.
Publicado: (2022) -
Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association
por: Anderson, Kirsten, et al.
Publicado: (2019) -
Pulmonary alveolar proteinosis: from classification to therapy
por: Salvaterra, Elena, et al.
Publicado: (2020) -
Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022) -
The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?
por: Trapnell, Bruce C., et al.
Publicado: (2019)